» Articles » PMID: 27453361

Observational Studies and the Difficult Quest for Causality: Lessons from Vaccine Effectiveness and Impact Studies

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2016 Jul 26
PMID 27453361
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Although randomized placebo-controlled trials (RCT) are critical to establish efficacy of vaccines at the time of licensure, important remaining questions about vaccine effectiveness (VE)-used here to include individual-level measures and population-wide impact of vaccine programmes-can only be answered once the vaccine is in use, from observational studies. However, such studies are inherently at risk for bias. Using a causal framework and illustrating with examples, we review newer approaches to detecting and avoiding confounding and selection bias in three major classes of observational study design: cohort, case-control and ecological studies. Studies of influenza VE, especially in seniors, are an excellent demonstration of the challenges of detecting and reducing such bias, and so we use influenza VE as a running example. We take a fresh look at the time-trend studies often dismissed as 'ecological'. Such designs are the only observational study design that can measure the overall effect of a vaccination programme [indirect (herd) as well as direct effects], and are in fact already an important part of the evidence base for several vaccines currently in use. Despite the great strides towards more robust observational study designs, challenges lie ahead for evaluating best practices for achieving robust unbiased results from observational studies. This is critical for evaluation of national and global vaccine programme effectiveness.

Citing Articles

A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Analysis of Québec Administrative Data.

Jiang C, Talbot D, Carazo S, Schnitzer M Stat Med. 2025; 44(5):e70025.

PMID: 39985144 PMC: 11845851. DOI: 10.1002/sim.70025.


Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025.

Blanquart F, Vieillefond V, Visseaux B, Abou Chakra C, Nunes M, Jacques A Euro Surveill. 2025; 30(7).

PMID: 39980426 PMC: 11843621. DOI: 10.2807/1560-7917.ES.2025.30.7.2500074.


Understanding Influenza Vaccine Clinical Performance: A Podcast.

Desai N, Lopalco P Adv Ther. 2024; 42(1):1-9.

PMID: 39556294 PMC: 11782400. DOI: 10.1007/s12325-024-03021-6.


Biases in COVID-19 vaccine effectiveness studies using cohort design.

Agampodi S, Tadesse B, Sahastrabuddhe S, Excler J, Kim J Front Med (Lausanne). 2024; 11:1474045.

PMID: 39540039 PMC: 11557388. DOI: 10.3389/fmed.2024.1474045.


Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness.

Li K, Shi X, Miao W, Tchetgen Tchetgen E J Am Stat Assoc. 2024; 119(547):1859-1870.

PMID: 39524693 PMC: 11545655. DOI: 10.1080/01621459.2023.2220935.


References
1.
Belongia E, Kieke B, Donahue J, Coleman L, Irving S, Meece J . Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011; 29(38):6558-63. DOI: 10.1016/j.vaccine.2011.07.002. View

2.
Simonsen L, Reichert T, Viboud C, Blackwelder W, Taylor R, Miller M . Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005; 165(3):265-72. DOI: 10.1001/archinte.165.3.265. View

3.
Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano C . Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010; 362(4):299-305. DOI: 10.1056/NEJMoa0905211. View

4.
Gilca R, Skowronski D, Douville-Fradet M, Amini R, Boulianne N, Rouleau I . Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015. PLoS One. 2015; 10(7):e0132195. PMC: 4511737. DOI: 10.1371/journal.pone.0132195. View

5.
Jackson M, Yu O, Nelson J, Naleway A, Belongia E, Baxter R . Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013; 178(8):1327-36. PMC: 7314269. DOI: 10.1093/aje/kwt124. View